Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1502 participants.

Also called NCT03452917

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 1,502 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03452917
Other papers using this trial's data
  • Effect of Out-of-Hospital Sodium Nitrite on Survival to Hospital Admission After Cardiac Arrest: A Randomized Clinical Trial JAMA, 2021-01-12 DOI, PubMed 33433575, PMC7804921 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03452917. Randomized; quadruple masking; primary purpose treatment. Start 2018-02-08 (actual); primary completion 2019-12-31 (actual). Results posted on 2023-05-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
Acronym
SNOCAT
Condition
Out-Of-Hospital Cardiac Arrest
Intervention (Drug)
Placebo
Intervention (Drug)
sodium nitrite 45 mg
Intervention (Drug)
sodium nitrite 60 mg
Lead sponsor
University of Washington (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct03452917
Content hash
21d80b2a6c3c537126e1c971198ac6476973831633296d483bc5ed31f1c46b41